|
 |
|
 |
 |
 |
 |
The various lipid
formulations of AMB have demonstrated antifungal efficacy at least
equivalent to the
|
|
conventional
product with significantly reduced nephrotoxicity. In: THE USE OF LIPID
FORMULATIONS
|
|
OF AMPHOTERICIN B
IN CANCER PATIENTS -- Rod Quilitz,
PharmD, Department of Pharmacy, H.
|
|
Lee Moffitt
Cancer Center & Research Institute, University of San Francisco, Cal.
|
|
|
http://www.moffitt.usf.edu/cancjrnl/v5n5/department3.html
|
|
|
|